Absci financials
$10.14+6.85%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $2.8M | $4.5M | $5.7M | $5.7M | $4.8M |
| Gross profit | $2.8M | $4.5M | $5.7M | $5.7M | $4.8M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$120.3M | -$108.9M | -$115.5M | -$106.8M | -$75.2M |
| Net income | -$115.2M | -$103.1M | -$110.6M | -$104.9M | -$103.2M |
| Net margin | −4113.7% | −2274.1% | −1933.6% | −1825.4% | −2159.0% |
| Diluted EPS | $-0.84 | $-0.94 | $-1.20 | $-1.15 | $-2.08 |
| EBITDA | -$108.6M | -$95.5M | -$80.2M | -$93.7M | -$68.6M |
| Operating cash flow | -$92.9M | -$72.4M | -$64.6M | -$81.3M | -$60.6M |
| Free cash flow | -$94.0M | -$72.8M | -$65.5M | -$97.5M | -$98.6M |
| Diluted shares | 136.8M | 110.2M | 92.0M | 90.8M | 49.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $20.0M | $41.2M | $72.4M | $60.0M | $252.6M |
| Short-term investments | $124.3M | $71.2M | $25.3M | $104.5M | $0.00 |
| Total debt | $873.0K | $4.0M | $8.6M | $14.0M | $9.5M |
| Total assets | $216.3M | $213.6M | $217.3M | $321.0M | $426.2M |
| Total liabilities | $26.8M | $34.5M | $41.1M | $46.6M | $60.1M |
| Shareholders' equity | $189.4M | $179.1M | $176.2M | $274.4M | $366.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology